Danaher (NYSE:DHR) issued its earnings results on Thursday. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.05, Bloomberg Earnings reports. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The company had revenue of $4.70 billion during the quarter, compared to analysts’ expectations of $4.54 billion. During the same period last year, the company posted $0.85 earnings per share. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. Danaher updated its Q2 guidance to $1.07-1.10 EPS and its FY18 guidance to $4.38-4.48 EPS.
NYSE:DHR opened at $102.40 on Thursday. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39. The company has a market cap of $70,935.84, a price-to-earnings ratio of 25.41, a P/E/G ratio of 1.93 and a beta of 1.03. Danaher has a fifty-two week low of $78.97 and a fifty-two week high of $104.82.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, March 29th will be paid a dividend of $0.16 per share. The ex-dividend date is Wednesday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 0.63%. This is an increase from Danaher’s previous quarterly dividend of $0.14. Danaher’s dividend payout ratio (DPR) is currently 15.88%.
In other news, insider Rainer Blair sold 51,080 shares of the firm’s stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $97.26, for a total value of $4,968,040.80. Following the transaction, the insider now owns 50,477 shares of the company’s stock, valued at approximately $4,909,393.02. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Walter G. Lohr sold 10,578 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $97.90, for a total transaction of $1,035,586.20. Following the completion of the transaction, the director now directly owns 19,821 shares in the company, valued at approximately $1,940,475.90. The disclosure for this sale can be found here. In the last three months, insiders sold 313,260 shares of company stock worth $31,657,786. Insiders own 11.90% of the company’s stock.
Hedge funds have recently modified their holdings of the company. Atlantic Trust Group LLC increased its stake in Danaher by 7.9% during the 3rd quarter. Atlantic Trust Group LLC now owns 2,223,836 shares of the conglomerate’s stock worth $190,762,000 after buying an additional 163,306 shares during the period. Prudential Financial Inc. increased its stake in Danaher by 5.2% during the 3rd quarter. Prudential Financial Inc. now owns 2,628,584 shares of the conglomerate’s stock worth $225,480,000 after buying an additional 130,621 shares during the period. Neville Rodie & Shaw Inc. increased its stake in Danaher by 1.3% during the 4th quarter. Neville Rodie & Shaw Inc. now owns 51,562 shares of the conglomerate’s stock worth $4,786,000 after buying an additional 650 shares during the period. QUANTRES ASSET MANAGEMENT Ltd increased its stake in Danaher by 21.4% during the 4th quarter. QUANTRES ASSET MANAGEMENT Ltd now owns 6,800 shares of the conglomerate’s stock worth $631,000 after buying an additional 1,200 shares during the period. Finally, Progressive Investment Management Corp increased its stake in Danaher by 5.9% during the 4th quarter. Progressive Investment Management Corp now owns 37,108 shares of the conglomerate’s stock worth $3,444,000 after buying an additional 2,074 shares during the period. 77.65% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: “Danaher (DHR) Issues Earnings Results” was first posted by Week Herald and is the property of of Week Herald. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://weekherald.com/2018/04/19/danaher-dhr-issues-earnings-results.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.